Europe Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)    

Code: BMIRE00027586 | Pages: 141 | Industry: Pharmaceuticals | Date: Dec 2022 |

The Europe lyophilized injectable market is expected to grow from US$ 808.34 million in 2022 to US$ 1,108.45 million by 2028. It is estimated to grow at a CAGR of 5.4% from 2022 to 2028.     

 

Increasing Demand for Contract Research Manufacturing Services

 

Freeze drying, or lyophilization, is a drying process that consists of the sublimation of ice crystals into vapor. Lyophilization is a process based on negative temperatures and the product's activity and stability. Moreover, in this process, active ingredients are better retained while limiting any damage to the product and avoiding any degradation of the molecules. Thus, freeze-drying is especially popular in pharmaceutical and diagnostic sectors. The increased quality and extended shelf life of lyophilized injectable drugs are creating opportunities to implement the lyophilization process in product manufacturing. Contract manufacturing and research services are in huge demand, delivering lyophilized injectable drugs to offer high-quality products to end users. Moreover, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, which is growing the demand for contract research and manufacturing services (CRAMs) for manufacturing. Furthermore, CRAMs play crucial roles in providing additional capacities to mitigate the risk of supply shortages by offering additional sites for pharmaceutical companies with multisite supply strategies and backup capacities. Furthermore, safe transit, extended pharmaceutical storage life, and many other advantages offered by lyophilized injectables are increasing the adoption of the lyophilization technique by many enterprises across the region.

 

Market Overview

The Europe lyophilized injectable market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022. Germany has a well-developed healthcare system. All legal & German residents are entitled to free necessary medical help, funded by a statutory contribution system. All residents must have medical insurance covering outpatient, inpatient, medical health, and prescription drug. Respiratory disease is one of the most common causes of death in Germany, which includes lung disorders and cancer. Moreover, changing lifestyles among the young population led to an increase in metabolic and autoimmune disorders, fueling the demand for lyophilized injectables. Respiratory disorders are one of the common causes of death along with lung cancer which are further supported by the increase in cardiovascular disorders which accounts for approximately 40% of deaths in Germany. According to the WHO 2020 report, Lung cancer is the third leading cause of death among the German population, with a prevalence rate of 10.3% of the total cancer cases. On the other hand, due to developed healthcare facilities and a rise in the prevalence of infectious diseases, Germany has a broad spectrum of antibiotics, leading to the increased use of antibiotics daily, creating the demand for lyophilized injectables. Moreover, high cost of transportation, increase in carbon footprints, and long shelf life have increased the demand for lyophilized drugs in the country. 

 

Europe Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

 

Europe Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Europe Lyophilized Injectable Market Segmentation    

 

The Europe lyophilized injectable market is segmented based on type of packaging, type of delivery, indication, end user, and country.

  • Based on type of packaging, the Europe lyophilized injectable market is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. The single-use vials segment held the largest market share in 2022.

In terms of type of delivery, the Europe lyophilized injectable market is categorized into prefilled diluent syringes, single-step devices, proprietary reconstitution devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2022.

  • Based on indication, the Europe lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and others. The metabolic and oncology conditions segment held the largest market share in 2022.
  • Based on end user, the Europe lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2022.
  • Based on country, the Europe lyophilized injectable market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.    
  • Aristopharma Ltd.; Baxter; CordenPharma International; Credence MedSystems, Inc.; Curia Global, Inc.; Jubilant HollisterStier (Jubilant Pharma Limited); Nipro; Recipharm AB; S.G. Biopharm Pvt. Ltd.; and Vetter Pharma are among the leading companies operating in the Europe lyophilized injectable market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Lyophilized Injectable Market – By Type of Packaging

1.3.2        Europe Lyophilized Injectable Market – By Type of Delivery

1.3.3        Europe Lyophilized Injectable Market – By Indication

1.3.4        Europe Lyophilized Injectable Market – By End User

1.3.5        Europe Lyophilized Injectable Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Lyophilized Injectable Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Lyophilized Injectable Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Demand for Contract Research Manufacturing Services

5.1.2        Increasing Demand of Biologics

5.2         Market Restraints

5.2.1        Product Recalls

5.3         Market Opportunities

5.3.1        Expansion of Pipeline of Lyophilized Injectable Drugs

5.4         Future Trends

5.4.1        Advancement in Lyophilized Packaging

5.5         Impact Analysis

6.           Lyophilized Injectable Market– Europe Analysis

6.1         Europe Lyophilized Injectable Market Revenue Forecast and Analysis

7.           Europe Lyophilized Injectable Market Analysis – By Type of Packaging

7.1         Overview

7.2         Europe Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

7.3         Single-use vials

7.3.1        Overview

7.3.2        Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Point-of-Care Reconstitution

7.4.1        Overview

7.4.2        Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Specialty Packaging

7.5.1        Overview

7.5.2        Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Lyophilized Injectable Market Analysis – By Type of Delivery

8.1         Overview

8.2         Europe Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

8.3         Prefilled Diluent Syringes

8.3.1        Overview

8.3.2        Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Single Step Devices

8.4.1        Overview

8.4.2        Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Proprietary Reconstitution Devices

8.5.1        Overview

8.5.2        Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Multi-Step Devices

8.6.1        Overview

8.6.2        Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Lyophilized Injectable Market Analysis – By Indication

9.1         Overview

9.2         Europe Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

9.3         Metabolic and Oncology Conditions

9.3.1        Overview

9.3.2        Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Autoimmune Diseases

9.5.1        Overview

9.5.2        Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Indications

9.6.1        Overview

9.6.2        Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Lyophilized Injectable Market Analysis – By End User

10.1      Overview

10.2      Europe Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Ambulatory Surgical Centers

10.4.1     Overview

10.4.2     Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Specialty Clinics

10.5.1     Overview

10.5.2     Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Other End Users

10.6.1     Overview

10.6.2     Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.        Europe Lyophilized Injectable Market – Country Analysis

11.1      Overview

11.1.1     Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

11.1.1.1       Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.1.1       Overview

11.1.1.1.1       Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.1.2       Germany: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.1.3       Germany: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.1.4       Germany: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.1.5       Germany: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.2       UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.2.1       Overview

11.1.1.2.2       UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.2.3       UK: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.2.4       UK: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.2.5       UK: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.2.6       UK: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.3       France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.3.1       Overview

11.1.1.3.2       France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.3.3       France: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.3.4       France: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.3.5       France: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.3.6       France: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.4       Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.4.1       Overview

11.1.1.4.2       Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.4.3       Italy: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.4.4       Italy: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.4.5       Italy: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.4.6       Italy: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.5       Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.5.1       Overview

11.1.1.5.2       Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.5.3       Spain: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.5.4       Spain: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.5.5       Spain: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.5.6       Spain: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

11.1.1.6       Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.6.3       Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)

11.1.1.6.4       Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)

11.1.1.6.5       Rest of Europe: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)

11.1.1.6.6       Rest of Europe: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Baxter

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Nipro

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Curia Global, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Recipharm AB

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Vetter Pharma

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Jubilant HollisterStier (Jubilant Pharma Limited)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Aristopharma Ltd.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      CordenPharma International

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Credence MedSystems, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   S.G. Biopharm Pvt. Ltd.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Germany: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Germany: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Germany: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             UK: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             UK: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             UK: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             UK: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          France: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          France: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          France: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          France: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14.          Italy: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 15.          Italy: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 16.          Italy: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 17.          Italy: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 18.          Spain: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 19.          Spain: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 20.          Spain: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 21.          Spain: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 22.          Rest of Europe: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)

Table 23.          Rest of Europe: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)

Table 24.          Rest of Europe: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 25.          Rest of Europe: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 26.          Recent Inorganic Growth Strategies

Table 27.          Recent Organic Growth Strategies

Table 28.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Lyophilized Injectable Market Segmentation

Figure 2.           Europe Lyophilized Injectable Market – By Country

Figure 3.           Europe Lyophilized Injectable Market Overview

Figure 4.           Europe Lyophilized Injectable Market, By Type of Packaging

Figure 5.           Europe Lyophilized Injectable Market, By Country

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Europe Lyophilized Injectable Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Lyophilized Injectable Market– Revenue Forecast and Analysis

Figure 10.        Europe Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)

Figure 11.        Europe Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)

Figure 15.        Europe Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)

Figure 20.        Europe Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Europe Lyophilized Injectable Market, by End User, 2021 and 2028 (%)

Figure 25.        Europe Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Europe: Lyophilized Injectable Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 30.        Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)

Figure 31.        Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32.        UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 33.        France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 34.        Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 35.        Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 36.          Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)

  1. Aristopharma Ltd.
  2. Baxter
  3. CordenPharma International
  4. Credence MedSystems, Inc.
  5. Curia Global, Inc.
  6. Jubilant HollisterStier (Jubilant Pharma Limited)
  7. Nipro
  8. Recipharm AB
  9. S.G. Biopharm Pvt. Ltd.
  10. Vetter Pharma     
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000